Rob Lester, well-known member of ELPCSG and former Chair of the group, has spoken to the Dundee Courier about his treatment for advanced prostate cancer with Abiraterone, the importance of cancer research amid the COVID-19 pandemic, and his support for a major fundraising appeal being launched by the Institute of Cancer Research (ICL). Read more here